Literature DB >> 28357965

Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype?

T Lopes1, R Cable2, C Pistorius2, T Maponga1, S Ijaz3, W Preiser1, R Tedder3, M I Andersson1.   

Abstract

Hepatitis E virus (HEV) infection is a major cause of acute hepatitis worldwide. This infection causes major water-borne outbreaks in low- and middle-income countries, whilst in industrialised countries this infection is zoonotic. These differences in epidemiology are related to different HEV genotypes. HEV genotype 3 is a zoonotic infection, whilst genotype 2 causes large outbreaks. This study determined the seroprevalence of HEV in blood donors from the Western Cape. Anti-hepatitis A virus (anti-HAV) antibody was detected in 184/300 (61%) donors. Antibody to HEV (anti-HEV) was detected in 78 of 300 donors (26%). It was highest in mixed race donors (62/100), followed by white donors (23/100) and lowest in black donors (19/100) P = 0.019. Since it is thought that genotypes 1 and 2 predominate both viruses would be acquired by the oro-faecal route, it is surprising that HEV seroprevalence does not mirror that of HAV. We postulate that this may reflect differences in socio-economic status and consumption of dietary meat. So the marked divergence between HEV and HAV seroprevalence may be the result of different routes of transmission. Further data are needed to explore the risk factors associated with HEV infection.

Entities:  

Keywords:  Epidemiology; hepatitis E; liver infection; viral hepatitis

Mesh:

Substances:

Year:  2017        PMID: 28357965      PMCID: PMC9203323          DOI: 10.1017/S0950268817000565

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  12 in total

Review 1.  Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.

Authors:  Kathryn H Jacobsen; Steven T Wiersma
Journal:  Vaccine       Date:  2010-08-17       Impact factor: 3.641

Review 2.  Hepatitis E virus infection: An underdiagnosed infection in transplant patients in Southern Africa?

Authors:  Monique I Andersson; Piers A Stead; Tongai Maponga; Helen van der Plas; Wolfgang Preiser
Journal:  J Clin Virol       Date:  2015-06-24       Impact factor: 3.168

3.  Immune reconstitution hepatitis E: a neglected complication of antiretroviral therapy in Africa?

Authors:  Monique I Andersson; Wolfgang Preiser; Tongai G Maponga; Izak Heys; Jantjie J Taljaard; Christo van Rensburg; Richard S Tedder; Samreen Ijaz
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

4.  Assessment of the risks for human health of adenoviruses, hepatitis A virus, rotaviruses and enteroviruses in the Buffalo River and three source water dams in the Eastern Cape.

Authors:  Vincent N Chigor; Timothy Sibanda; Anthony I Okoh
Journal:  Food Environ Virol       Date:  2014-03-28       Impact factor: 2.778

5.  Prevalence of hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus and hepatitis E virus as causes of acute viral hepatitis in North India: a hospital based study.

Authors:  P Jain; S Prakash; S Gupta; K P Singh; S Shrivastava; D D Singh; J Singh; A Jain
Journal:  Indian J Med Microbiol       Date:  2013 Jul-Sep       Impact factor: 0.985

Review 6.  Hepatitis E.

Authors:  Nassim Kamar; Richard Bendall; Florence Legrand-Abravanel; Ning-Shao Xia; Samreen Ijaz; Jacques Izopet; Harry R Dalton
Journal:  Lancet       Date:  2012-04-30       Impact factor: 79.321

Review 7.  Worldwide epidemiology of hepatitis A virus infection.

Authors:  C N Shapiro; H S Margolis
Journal:  J Hepatol       Date:  1993       Impact factor: 25.083

Review 8.  A systematic review of the epidemiology of hepatitis E virus in Africa.

Authors:  Jong-Hoon Kim; Kenrad E Nelson; Ursula Panzner; Yogita Kasture; Alain B Labrique; Thomas F Wierzba
Journal:  BMC Infect Dis       Date:  2014-06-05       Impact factor: 3.090

9.  Hepatitis E virus: Western Cape, South Africa.

Authors:  Richie G Madden; Sebastian Wallace; Mark Sonderup; Stephen Korsman; Tawanda Chivese; Bronwyn Gavine; Aniefiok Edem; Roxy Govender; Nathan English; Christy Kaiyamo; Odelia Lutchman; Annemiek A van der Eijk; Suzan D Pas; Glynn W Webb; Joanne Palmer; Elizabeth Goddard; Sean Wasserman; Harry R Dalton; C Wendy Spearman
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

10.  Hepatitis E epidemic, Uganda.

Authors:  Eyasu H Teshale; Christopher M Howard; Scott P Grytdal; Thomas R Handzel; Vaughn Barry; Saleem Kamili; Jan Drobeniuc; Samuel Okware; Robert Downing; Jordan W Tappero; Barnabas Bakamutumaho; Chong Gee Teo; John W Ward; Scott D Holmberg; Dale J Hu
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more
  4 in total

Review 1.  Epidemiology of Genotype 1 and 2 Hepatitis E Virus Infections.

Authors:  Kenrad E Nelson; Alain B Labrique; Brittany L Kmush
Journal:  Cold Spring Harb Perspect Med       Date:  2019-06-03       Impact factor: 6.915

2.  Low seroprevalence of hepatitis E virus in pregnant women in an urban area near Pretoria, South Africa.

Authors:  Omphile E Simani; Tshegofatso P Seipone; Gloria Selabe; L Mapaseka Seheri; M Jeffrey Mphahlele; Simnikiwe H Mayaphi; A Duncan Steele
Journal:  IJID Reg       Date:  2021-12-11

3.  Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009-2017.

Authors:  R Bassal; M Wax; R Shirazi; T Shohat; D Cohen; D David; S Abu-Mouch; Y Abu-Ghanem; E Mendelson; Z Ben-Ari; O Mor
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 4.  Transfusion-transmitted hepatitis E: What we know so far?

Authors:  Carmen Ka Man Cheung; Sunny Hei Wong; Alvin Wing Hin Law; Man Fai Law
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.